Cargando…

Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine

Previously, we developed a non-replicating recombinant baculovirus coated with human endogenous retrovirus envelope protein (AcHERV) for enhanced cellular delivery of human papillomavirus (HPV) 16L1 DNA. Here, we report the immunogenicity of an AcHERV-based multivalent HPV nanovaccine in which the L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hansam, Lee, Hee-Jung, Heo, Yoon-Ki, Cho, Yeondong, Gwon, Yong-Dae, Kim, Mi-Gyeong, Park, Ki Hoon, Oh, Yu-Kyoung, Kim, Young Bong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997520/ https://www.ncbi.nlm.nih.gov/pubmed/24759938 http://dx.doi.org/10.1371/journal.pone.0095961

Ejemplares similares

Sublingual Immunization of Trivalent Human Papillomavirus DNA Vaccine in Baculovirus Nanovector for Protection against Vaginal Challenge
por: Lee, Hee-Jung, et al.
Publicado: (2015)

Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1
por: Gwon, Yong-Dae, et al.
Publicado: (2016)

Detection of Pig Cells Harboring Porcine Endogenous Retroviruses in Non-Human Primate Bladder After Renal Xenotransplantation
por: Heo, Yoonki, et al.
Publicado: (2019)

Protective Efficacy of a Human Endogenous Retrovirus Envelope-Coated, Nonreplicable, Baculovirus-Based Hemagglutin Vaccine against Pandemic Influenza H1N1 2009
por: Choi, Jae-Yoo, et al.
Publicado: (2013)

Immunogenicity of Bivalent Human Papillomavirus DNA Vaccine Using Human Endogenous Retrovirus Envelope-Coated Baculoviral Vectors in Mice and Pigs
por: Lee, Hee-Jung, et al.
Publicado: (2012)

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant
por: Choi, Hyo Jung, et al.
Publicado: (2015)

Transmission of Porcine Endogenous Retrovirus Produced from Different Recipient Cells In Vivo
por: Kim, Nayoung, et al.
Publicado: (2016)

Comparison of Repellency Effect of Mosquito Repellents for DEET, Citronella, and Fennel Oil
por: Yoon, Jong Kwang, et al.
Publicado: (2015)

Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles
por: Kines, Rhonda C., et al.
Publicado: (2015)

Mucosal Delivery of Human Papillomavirus Pseudovirus-Encapsidated Plasmids Improves Potency of DNA Vaccination
por: Graham, Barney S., et al.
Publicado: (2010)

Hepatitis E virus ORF2 protein over-expressed by baculovirus in hepatoma cells, efficiently encapsidates and transmits the viral RNA to naïve cells
por: Parvez, Mohammad K, et al.
Publicado: (2011)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
por: Nooraei, Saghi, et al.
Publicado: (2021)

RNA Encapsidation and Packaging in the Phleboviruses
por: Hornak, Katherine E., et al.
Publicado: (2016)

Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
por: Premanand, Balraj, et al.
Publicado: (2018)

Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus
por: Tuboly, T., et al.
Publicado: (1994)

Baculovirus entire ORF1629 is not essential for viral replication
por: Gwak, Won Seok, et al.
Publicado: (2019)

Encapsidation of Viral RNA in Picornavirales: Studies on Cowpea Mosaic Virus Demonstrate Dependence on Viral Replication
por: Kruse, Inga, et al.
Publicado: (2019)

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020)

Addressing Nanovaccine Strategies for Tilapia
por: Thompson, Kim D., et al.
Publicado: (2023)

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
por: Spencer, Sarah, et al.
Publicado: (2021)

Foamy Virus Assembly with Emphasis on Pol Encapsidation
por: Lee, Eun-Gyung, et al.
Publicado: (2013)

Translational Cross-Activation of the Encapsidated RNA of Potexviruses
por: Arkhipenko, M. V., et al.
Publicado: (2017)

The Nucleocapsid of Paramyxoviruses: Structure and Function of an Encapsidated Template
por: Bloyet, Louis-Marie
Publicado: (2021)

Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military
por: Gao, Dongqi, et al.
Publicado: (2016)

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022)

Enhancement of Immune Responses Elicited by Nanovaccines through a Cross-Presentation Pathway
por: Kim, Cheol-Gyun, et al.
Publicado: (2023)

Roles for Human Papillomavirus Type 16 L1 Cysteine Residues 161, 229, and 379 in Genome Encapsidation and Capsid Stability
por: Ryndock, Eric J., et al.
Publicado: (2014)

A SELEX-Screened Aptamer of Human Hepatitis B Virus RNA Encapsidation Signal Suppresses Viral Replication
por: Feng, Hui, et al.
Publicado: (2011)

The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles
por: Pattnaik, Asit K., et al.
Publicado: (1995)

Oligomerization of Baculovirus LEF-11 Is Involved in Viral DNA Replication
por: Dong, Zhan-Qi, et al.
Publicado: (2015)

Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6–35 Months
por: Lee, Jee Hyun, et al.
Publicado: (2019)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
por: Mo, Zhaojun, et al.
Publicado: (2017)

Molecular Basis of Encapsidation of Hepatitis C Virus Genome
por: Shi, Guoli, et al.
Publicado: (2018)

Encapsidation of Different Plasmonic Gold Nanoparticles by the CCMV CP
por: Durán-Meza, Ana L., et al.
Publicado: (2020)

Immunopurification applied to the study of virus protein composition and encapsidation
por: Escors, David, et al.
Publicado: (2004)

Encapsidation of Staufen-2 Enhances Infectivity of HIV-1
por: Balakrishnan, Kannan, et al.
Publicado: (2021)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6dd4bkh4in7367j3ihhjjd5oe